PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard
/PRNewswire/ -- PreciseDx, a leading innovator in AI-powered, patient-specific disease analysis, today announced its recent publication in Breast Cancer...